StockWatch
·
Medical/Dental Instruments
SplitJul 6, 2026, 04:22 PM

Profusa Announces 1-for-25 Reverse Stock Split

AI Summary

Profusa, Inc. announced a 1-for-25 reverse stock split of its common stock, effective July 7, 2026, at 12:01 a.m. ET. This action, approved by stockholders on June 23, 2026, and finalized by the CEO, will consolidate every twenty-five shares into one. As a result, outstanding shares will reduce from approximately 13.2 million to 530 thousand, while authorized shares remain at 601 million. The company's common stock will trade on Nasdaq on a post-split basis under the existing ticker PFSA with a new CUSIP, and cash will be paid for any fractional shares.

Key Highlights

  • Stockholders approved a reverse stock split at a ratio of 1-for-5 to 1-for-200.
  • Company's CEO approved a 1-for-25 reverse stock split of common stock.
  • Reverse stock split becomes effective on July 7, 2026, at 12:01 a.m. ET.
  • Outstanding shares will decrease from approximately 13.2 million to 530 thousand.
  • Authorized shares will remain unchanged at 601 million.
  • New CUSIP number for common stock will be 74319X 306.
  • No fractional shares will be issued; stockholders will receive cash in lieu.
  • 2025 net loss per common share (basic & diluted) adjusted from $(107.01) to $(2,675.35) post-split.